Pacer Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $73.9M | Sell |
277,133
-36,569
| -12% | -$9.9M | 0.21% | 121 |
|
|
2025
Q4 | $78.7M | Buy |
313,702
+7,956
| +3% | +$2.11M | 0.2% | 109 |
|
|
2025
Q3 | $87.8M | Buy |
305,746
+298,415
| +4,071% | +$80M | 0.22% | 95 |
|
|
2025
Q2 | $1.92M | Buy |
7,331
+3,028
| +70% | +$737K | ﹤0.01% | 1037 |
|
|
2025
Q1 | $1M | Sell |
4,303
-2,425
| -36% | -$588K | ﹤0.01% | 1202 |
|
|
2024
Q4 | $1.54M | Sell |
6,728
-18,654
| -73% | -$4.28M | ﹤0.01% | 1137 |
|
|
2024
Q3 | $5.67M | Buy |
25,382
+5,784
| +30% | +$1.27M | 0.01% | 618 |
|
|
2024
Q2 | $3.99M | Buy |
19,598
+2,705
| +16% | +$550K | 0.01% | 667 |
|
|
2024
Q1 | $3.69M | Sell |
16,893
-2,976
| -15% | -$656K | 0.01% | 666 |
|
|
2023
Q4 | $4.52M | Buy |
19,869
+12,095
| +156% | +$2.54M | 0.01% | 589 |
|
|
2023
Q3 | $1.56M | Sell |
7,774
-1,341
| -15% | -$283K | 0.01% | 661 |
|
|
2023
Q2 | $1.89M | Buy |
9,115
+2,650
| +41% | +$514K | 0.01% | 755 |
|
|
2023
Q1 | $1.27M | Buy |
6,465
+3,929
| +155% | +$808K | 0.01% | 829 |
|
|
2022
Q4 | $513K | Sell |
2,536
-774
| -23% | -$151K | ﹤0.01% | 1233 |
|
|
2022
Q3 | $582K | Sell |
3,310
-2,799
| -46% | -$573K | ﹤0.01% | 698 |
|
|
2022
Q2 | $1.23M | Sell |
6,109
-224,988
| -97% | -$48M | 0.01% | 505 |
|
|
2022
Q1 | $52.3M | Buy |
231,097
+154,391
| +201% | +$36.3M | 0.43% | 55 |
|
|
2021
Q4 | $20.7M | Buy |
76,706
+14,711
| +24% | +$3.64M | 0.21% | 77 |
|
|
2021
Q3 | $15M | Buy |
61,995
+8,603
| +16% | +$2.17M | 0.19% | 76 |
|
|
2021
Q2 | $12.7M | Buy |
53,392
+46,928
| +726% | +$10.7M | 0.18% | 84 |
|
|
2021
Q1 | $1.42M | Sell |
6,464
-876
| -12% | -$176K | 0.02% | 629 |
|
|
2020
Q4 | $1.28M | Sell |
7,340
-4,045
| -36% | -$699K | 0.02% | 596 |
|
|
2020
Q3 | $1.84M | Sell |
11,385
-1,624
| -12% | -$257K | 0.04% | 441 |
|
|
2020
Q2 | $1.86M | Buy |
+13,009
| New | +$1.8M | 0.04% | 395 |
|
|
2020
Q1 | – | Sell |
-13,131
| Closed | -$1.91M | – | 912 |
|
|
2019
Q4 | $1.91M | Sell |
13,131
-993
| -7% | -$143K | 0.09% | 280 |
|
|
2019
Q3 | $2.04M | Buy |
14,124
+1,503
| +12% | +$219K | 0.05% | 476 |
|
|
2019
Q2 | $1.88M | Buy |
12,621
+2,174
| +21% | +$303K | 0.05% | 513 |
|
|
2019
Q1 | $1.37M | Buy |
+10,447
| New | +$1.29M | 0.04% | 374 |
|
|
2018
Q4 | – | Sell |
-6,174
| Closed | -$921K | – | 822 |
|
|
2018
Q3 | $921K | Buy |
6,174
+834
| +16% | +$127K | 0.03% | 682 |
|
|
2018
Q2 | $824K | Buy |
5,340
+866
| +19% | +$131K | 0.04% | 721 |
|
|
2018
Q1 | $622K | Buy |
4,474
+458
| +11% | +$67.3K | 0.03% | 660 |
|
|
2017
Q4 | $550K | Buy |
4,016
+1,238
| +45% | +$164K | 0.04% | 673 |
|
|
2017
Q3 | $360K | Buy |
2,778
+272
| +11% | +$36.3K | 0.03% | 807 |
|
|
2017
Q2 | $332K | Buy |
2,506
+202
| +9% | +$24.7K | 0.03% | 808 |
|
|
2017
Q1 | $284K | Buy |
2,304
+77
| +3% | +$9.12K | 0.03% | 781 |
|
|
2016
Q4 | $246K | Sell |
2,227
-14
| -0.6% | -$1.55K | 0.04% | 785 |
|
|
2016
Q3 | $265K | Sell |
2,241
-14
| -0.6% | -$1.65K | 0.04% | 683 |
|
|
2016
Q2 | $252K | Buy |
2,255
+106
| +5% | +$11.4K | 0.04% | 676 |
|
|
2016
Q1 | $216K | Buy |
2,149
+225
| +12% | +$21.6K | 0.05% | 388 |
|
|
2015
Q4 | $204K | Buy |
+1,924
| New | +$198K | 0.05% | 378 |
|
Other funds holding LH
VCM
VPM
Pacer Advisors's LH Position: Q1 2026 in Review
Pacer Advisors reduced its Labcorp (LH) stake by 12% in Q1 2026, selling an estimated $9.9M and leaving 277,133 shares worth $73.9M. The position accounts for 0.21% of the portfolio, ranked #121.
Pacer Advisors first reported a position in LH in Q4 2015 and has held it in 40 quarters since. The position peaked at $87.8M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Pacer Advisors held 277,133 shares of Labcorp worth $73.9M as of Q1 2026.
- Pacer Advisors sold 36,569 Labcorp shares in Q1 2026, an estimated $9.9M.
- Labcorp made up 0.21% of Pacer Advisors's portfolio in Q1 2026, its #121 holding.
- Pacer Advisors first reported a position in Labcorp in Q4 2015 and has held it in 40 quarters since.
- Pacer Advisors's Labcorp position peaked at $87.8M in Q3 2025.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.